Fertility preservation is not exclusively for cancer patients; it also applies to individuals who marry or have children later in life, experience declining ovarian function, or require treatments that may impair reproductive capacity. This article outlines definitions, target populations, techniques, procedures, and common questions to help you establish an actionable decision-making framework.
I. What is Fertility Preservation?
Fertility preservation refers to the medical preservation of “future reproductive resources” before fertility declines or is compromised, enabling pregnancy attempts at an appropriate time. Commonly preserved biological materials include eggs, embryos, and ovarian tissue. The European Society of Human Reproduction and Embryology (ESHRE) guidelines for female fertility preservation systematically recommend egg/embryo freezing and ovarian tissue cryopreservation as primary approaches.
The core value of fertility preservation lies not in “guaranteeing outcomes,” but in preserving greater probabilistic options for an uncertain future: transforming the “impact of time on ovarian and gamete quality” into “manageable medical decisions.”
Expert Note: Fertility preservation is not about “the earlier, the better,” but rather “evaluating options early when physical conditions permit and before foreseeable risks arise.” Earlier assessment typically allows for more available techniques and higher egg retrieval efficiency.
II. Who Should Prioritize Fertility Preservation?
The following groups do not equate to “mandatory” cases but warrant fertility preservation clinic evaluation (including AMH, basal follicular count, hormone levels, ultrasound, and medical history/medication).
1) Cancer or hematological disease patients (undergoing chemotherapy/radiotherapy/bone marrow transplantation, etc.)
Multiple cancer treatments carry potential gonadal toxicity, potentially causing diminished ovarian reserve, amenorrhea, or impaired fertility. Updated ASCO guidelines for fertility preservation in cancer patients emphasize: Fertility counseling should be initiated early upon diagnosis, with established methods (e.g., egg, embryo, or ovarian tissue freezing) available.
2) Individuals requiring non-cancer treatments that may impair ovarian function
Examples include immunosuppressive regimens for certain autoimmune diseases or non-cancer conditions requiring pelvic radiation therapy. Clinicians should apply similar principles: Evaluate preservation options before treatment.
3) Women planning to delay childbearing (“elective egg freezing/cryopreservation” candidates)
ESHRE guidelines indicate that with advancements in vitrification techniques, egg freezing has become a key strategy for addressing age-related fertility decline. However, its limitations must be understood: it preserves only the current state of eggs and cannot mitigate other risks during future pregnancies.
4) Individuals with diminished ovarian reserve or risk of premature ovarian failure
Such as history of ovarian surgery, recurrent ovarian cysts, or family history of early menopause. For these individuals, the key is to advance the “assessment window,” as ovarian reserve decline often occurs silently.
5) Individuals requiring surgery or treatment that may affect the ovaries/uterus
For example, before or after treatment for severe endometriosis or ovarian tumors (benign/borderline). Suitability for preservation methods varies significantly across conditions, typically requiring joint decision-making between reproductive medicine and relevant specialties.
6) Adolescents or individuals unable to delay treatment and unsuitable for ovarian stimulation
Examples include prepubescent girls or those requiring immediate treatment initiation. Ovarian tissue cryopreservation may be considered in certain scenarios, particularly when “time for ovarian stimulation and egg retrieval is unavailable.”
Expert Note: For those facing imminent treatment, the decision focus shifts from “which technology is ideal” to “which approach is feasible and manageable without delaying treatment.”
III. Understanding Mainstream Technologies
Fertility preservation is not a single technique but a toolkit tailored to “timing, age, medical condition, presence of a partner/donor, and treatment urgency.”
1) Egg Freezing (Vitrification)
Suitable for: Independent of a partner; emphasizes “preserving current egg quality.”
Key Evidence: ASRM/relevant guidelines confirm mature egg freezing is no longer considered experimental. Vitrified eggs demonstrate comparable clinical outcomes post-thaw to fresh eggs (though outcomes still depend on age, egg quantity, and lab proficiency).
Key Limitations: Strong correlation between egg quantity and age; egg freezing does not guarantee future pregnancy but enhances future options.
2) Embryo Freezing
Suitability: Established stable partner or confirmed use of donor sperm; freezing occurs after embryo formation.
Advantage Logic: Embryos represent a stage of “completed fertilization and early developmental screening,” offering more mature management under certain laboratory conditions; however, it involves practical issues such as legal/ethical considerations and potential changes in both parties' intentions.
3) Ovarian Tissue Cryopreservation
Applicable Scenarios: When there is insufficient time for ovarian stimulation and egg retrieval, pre-pubertal patients, or certain special medical situations; involves harvesting and cryopreserving a portion of ovarian cortical tissue.
Risks and limitations: Requires careful evaluation for some cancer patients (e.g., potential tissue reimplantation risks). Protocols should be jointly developed by oncology and reproductive medicine teams.
4) “Does prolonged freezing degrade egg quality?”
Research indicates: The duration of liquid nitrogen storage for vitrified eggs does not appear to affect outcomes like survival, fertilization, pregnancy, or live birth (under compliant storage conditions). This implies that the decision-making focus should typically shift from “how long can they be frozen” to “the age and quality of the eggs at the time of freezing.”
Expert advice: Rather than repeatedly fixating on “how many years they can be frozen,” it is more advisable to concentrate on two key factors: ① Your current age and ovarian reserve; ② The cumulative number of mature eggs obtainable from one or multiple egg retrieval cycles.
IV. Frequently Asked Questions
Q1: Is fertility preservation the same as egg freezing?
No. Egg freezing is just one method of fertility preservation. Individuals with stronger medical indications (e.g., before cancer treatment) may consider multiple options like egg, embryo, or ovarian tissue preservation.
Q2: Does freezing eggs guarantee future success?
No. Egg freezing preserves the current state of your eggs, but future pregnancy outcomes depend on uterine conditions, sperm quality, embryo development, pregnancy complication risks, and other factors. ASRM's Ethics and Practice Guidelines emphasize that egg freezing offers opportunity and possibility, not guaranteed results.
Q3: What is the approximate survival rate of thawed eggs?
Significant variation exists between centers and individuals. However, recent studies and reports indicate thawed egg survival rates often fall within a high range. For example, one study on vitrified oocyte thaw performance reported an average survival rate of approximately 89.1% (note: sample size and methodology affect extrapolation).
Q4: Will fertility preservation delay cancer treatment?
Whether treatment is delayed depends on tumor type, stage, urgency of therapy, and center coordination efficiency. Studies on referral and treatment windows indicate that actual referral rates are low in clinical practice, and there is often a time gap between initial cancer diagnosis and treatment initiation. This suggests that early communication and establishing pathways are more critical for minimizing time loss.
Q5: Can I preserve fertility without a partner?
Egg freezing is generally evaluable, but feasibility depends on local regulations and institutional policies. Medically, the core considerations are ovarian reserve, health status, and timing.
Q6: Is one egg retrieval cycle sufficient?
There is no universal answer. Clinicians will break down the goal into factors such as “desired number of children,” “your current age,” “number of mature eggs obtainable in one cycle,” and “willingness to undergo multiple cycles,” then develop a personalized plan. It is important to emphasize: this is a matter of probability and should not be understood in absolute terms.
V. Fertility Preservation Process
Below is a general process using “egg/embryo freezing” as an example. Specific steps may vary by institution:
Stage Your Actions Key Medical Assessments Common Outcomes
1. Initial Evaluation Provide menstrual history, surgical history, family history, medication history, past fertility history; complete hormone/AMH/transvaginal ultrasound tests Assess ovarian reserve, ovulation status, contraindications; evaluate urgency for treatment (e.g., tumors) Recommendation for preservation and preferred method (oocytes/embryos/tissue)
2. Protocol Development Confirm presence of partner/donor; establish timeframe, budget, and psychological expectations Ovulation induction protocol, egg retrieval timing, anesthesia risks, complication risks Personalized stimulation plan and follow-up schedule
3. Stimulation Monitoring Administer medications as prescribed; undergo ultrasound and hormone monitoring Monitor follicle count/development and manage OHSS risks Trigger injection timing, egg retrieval schedule
4. Egg Retrieval/Fertilization/Freezing Egg retrieval; fertilization and culture if embryos are frozen; subsequent vitrification and storage Mature egg rate, fertilization and embryo development (if applicable) Number of frozen embryos, storage records, follow-up visit plan
5. Follow-up Management Regular contact updates, informed consent, storage duration & fees (per local regulations) Storage compliance & rights arrangements Thawing upon need to resume IVF process
Expert Note: Treat “process efficiency” as a key variable. For medically indicated cases (e.g., pre-cancer treatment), rapid assessment and initiation often depend on multidisciplinary collaboration and expedited pathways—not just individual willingness.
VI. Summary Box
Fertility Preservation Key Points
Definition: Preserving eggs/embryos/ovarian tissue before fertility decline or impairment to retain future pregnancy options.
Key Candidates: Cancer patients or those undergoing gonadotoxic treatment, individuals planning delayed childbearing, those with diminished ovarian reserve or high risk, or those unable to undergo ovarian stimulation in time.
Mainstream Techniques:
Oocyte cryopreservation (vitrification) and embryo freezing are common approaches; ovarian tissue cryopreservation is applicable in specific scenarios.
Key Reality:
It enhances “future availability” opportunities, not guaranteed outcomes. Decisions should be based on a comprehensive assessment of age, ovarian reserve, time window, urgency of medical condition, and personal plans.
For fertility consultation in Kyrgyzstan, please contact your dedicated consultant
/Fertility Consultation /
Dr.Chan
Copy and add: Tulip_EnoChan
Or long press/scan the QR code to add
Tulip International Fertility Center
Technology aids fertility, fulfilling dreams for countless families
